A Study of Lonafarnib With or Without Ritonavir in Patients With HDV

Clinical trial NCT02968641 · WITHDRAWN

Trial details

NCT number: NCT02968641
Sponsor: Eiger BioPharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Delta Hepatitis

Primary completion: 2021-02-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.